References
1. Ari A, Restrepo R. Aerosol Delivery Device Selection for Spontaneously Breathing Patients. 2012. AARC Clinical Practice Guidelines. Respir Care
2012;57(4):613-626.
2. Ari A, Hess D, Myers TR, Rau JL. A guide to aerosol delivery devices for respiratory therapists 3rd. Irving, TX: American Association for Respiratory Care; 2013.
3. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health care–associated pneumonia 2003. Recommendations of the CDC and
the Healthcare Infection Control Practices Advisory Committee. MMWR Morb Mortal Wkly Rep 2004;53(RR–3):1-36.
4. Boe J, Dennis JH, O’Driscoll BR, Bauer TT, Carone M, Dautzenberg B, et al; European Respiratory Society Guidelines On the Use of Nebulizers. Eur Respir J
2001;18(1):228-242.
5. Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to
prevent patient-to-patient transmission. Infect Control Hosp Epidemol 2003;31(3):S6-S62.
NebuTech
®
896
0
Disposable Nebulizer Instructions for
Use and Cleaning (continued)
SLML 107 Rev C, June 2014
Pg 4
